LST1 and type 2 diabetes mellitus: This study leveraged scRNA-seq technology to comprehensively investigate two disease models, unveiling that early-stage T2DM, characterized by upregulated LST1 expression, triggers the activation of granulocyte efferocytosis and antigen presentation functions, perturbing immune homeostasis.